New ESG report reveals Beyond Meat's plant-based steak dramatically outperforms beef across sustainability metrics, using 93% less water and 88% less land while meeting heart-healthy standards.
Exicure lands major $15M investment package led by South Korean firm HiTron Systems, including strategic financing and leadership changes to maintain Nasdaq listing compliance.
Exicure lands major financing deals totaling $12M, with HiTron Systems becoming majority shareholder. Company addresses Nasdaq compliance with fresh capital injection.
Major expansion as Sol Strategies acquires three validators from Orangefin, boosting total staked SOL to 1.5M tokens with 9% APY. Deal includes key leadership addition.
Groundbreaking FDA approval for Zepbound demonstrates significant benefits: 25 fewer breathing interruptions per hour and up to 20% weight loss in OSA patients with obesity.
Kenorland Minerals maintains key ownership stakes with mining giants Sumitomo and Centerra through strategic share issuance, preserving important industry partnerships.
Intelligent Living Application Group sees massive revenue growth to $4.47M and dramatic profit improvement, while continuing strategic investments in smart lock R&D.
Teva Pharmaceutical will present Q4 2024 results and 2025 financial guidance. Join the conference call and webcast to get insights into the company's performance and future outlook.
Mining firm secures important funding through private placement, issuing 18.2M shares to advance Canadian exploration initiatives with tax benefits for subscribers.
Ultragenyx Pharmaceutical strengthens team with strategic RSU grants to 15 new non-executive officers, featuring four-year vesting schedule to drive long-term retention.